Show Summary Details
Page of

Pancreatic Neoplasmsa 

Pancreatic Neoplasmsa
Chapter:
Pancreatic Neoplasmsa
Author(s):

Randall K. Pearson

DOI:
10.1093/med/9780199373338.003.0044
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 19 February 2020

Almost uniformly, cancer of the pancreas is fatal and is increasingly a health problem. In the United States, the calculated incidence of pancreatic cancer in 2008 was 37,700, with 34,300 deaths due to the disease. The overall survival rate for persons with pancreatic cancer is less than 5%, the lowest 5-year survival rate of any cancer. This partly reflects the low resectability rate. Advanced age is the most common risk factor for pancreatic cancer, and as the population ages, the incidence of pancreatic cancer is predicted to increase. Only 10% to 15% of patients are candidates for curative resection (stage I and stage II disease), and more than 50% have unresectable stage IV disease with distant metastases.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.